Covid: China learnings help Indegene save lives of its employees in India

At a time when the second wave of the Covid-19 pandemic has wreaked havoc across the country, Indegene's practices can become a template for the corporate industry to manage the pandemic

Till the end of 2019, Dr. Saurabh Jain was in Beijing heading the China business at enterprise health tech firm Indegene. Bengaluru-headquartered Indegene has a large footprint in China with a significant medical affairs portfolio. After the coronavirus (Covid-19) outbreak was first identified in Wuhan, the most populous city in Central China, in December 2019, the company pilot tested an initiative headed by Jain in Wuhan. The team assisted doctors with data collation and deploying its medical writers to develop manuscripts for therapy tried on patients. This initiative was launched for Indian doctors in May 2020 in India.

These learnings